|
|
||||||||
1 Department of Kinesiology and Applied Physiology, University of Colorado, Boulder 80309; and Divisions of 2 Cardiology and 3 Geriatric Medicine, Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262
| |
ABSTRACT |
|---|
|
|
|---|
We tested the hypothesis
that regular endurance exercise prevents the age-related decline in
insulin action typically observed in healthy, sedentary adults. An
index of whole body insulin sensitivity (ISI), obtained from minimal
model analysis of insulin and glucose concentrations during a
frequently sampled intravenous glucose tolerance test, was determined
in 126 healthy adults: 25 young [27 ± 1 (SE) yr; 13 men/12
women] and 43 older (59 ± 1 yr; 20/13) sedentary and 25 young
(29 ± 1 yr; 12/13) and 33 older (60 ± 1 yr; 20/13)
endurance trained. ISI values were lower in the older vs. young adults
in both sedentary (
53%; 3.9 ± 0.3 vs. 7.0 ± 0.7 ×10
4 · min
1 · µU
1 · ml
1;
P < 0.01) and endurance-trained (
36%; 7.9 ± 0.6 vs. 12.4 ± 1.0 ×10
4
min
1 · µU
1 · ml
1;
P < 0.01) groups, but the value was 72-102%
higher in the trained subjects at either age (P < 0.01). In subgroup analysis of sedentary and endurance-trained adults
with similar body fat levels (n = 62), the age-related
reduction in ISI persisted only in the endurance-trained subjects
(12.9 ± 1.9 vs. 8.7 ± 1.2 ×10
4 · min
1 · µU
1 · ml
1;
P < 0.01). The results of the present study suggest
that habitual endurance exercise does not prevent the age-associated
decline insulin action. Moreover, the age-related reduction in ISI in endurance-trained adults appears to be independent of adiposity.
insulin resistance; sedentary; physical activity; glucose metabolism
| |
INTRODUCTION |
|---|
|
|
|---|
IT IS WELL DOCUMENTED THAT advancing age is associated with a decline in insulin action (i.e., development of insulin resistance) (10, 11, 15, 37, 41). Studies utilizing either the hyperinsulinemic, euglycemic glucose clamp (11, 15, 37) or minimal model (10, 41) techniques have demonstrated age-related reductions in insulin sensitivity ranging from 30 to 60% in healthy, sedentary men and women.
The decline in insulin action with age is thought to contribute to the high prevalence of impaired glucose tolerance and Type 2 diabetes among the elderly (17, 43). In addition, low insulin sensitivity is associated with increased rates of atherosclerotic vascular disease, in part through related metabolic disorders such as hyperinsulinemia, dyslidipemia, and hypertension. As such, insulin sensitivity represents a major independent factor in the etiology of age-associated coronary and cerebrovascular disease (8, 20, 24, 31).
In contrast to aging, regular aerobic exercise is associated with enhanced insulin sensitivity (26, 36, 39, 40) and a lower incidence of metabolic and cardiovascular diseases (5, 35). Moreover, it has been suggested that age-related declines in insulin sensitivity observed in healthy, sedentary adult humans do not occur in adults who regularly perform endurance exercise (39). However, there has been no direct test of this hypothesis. Absence or attenuation of this decline could contribute to the lower prevalence of age-related metabolic and cardiovascular diseases observed in habitually endurance-trained individuals (35).
Thus the primary purpose of the present investigation was to test the hypothesis that regular endurance exercise prevents the age-related decline in insulin sensitivity observed in healthy, sedentary adults. To address this aim, we employed a cross-sectional model that our laboratory has used successfully in the past to gain insight into issues relating to aging and regular aerobic exercise. Specifically, whole body insulin action was assessed in groups of healthy young and older sedentary and endurance-trained men and women.
| |
SUBJECTS AND METHODS |
|---|
|
|
|---|
Subjects. One hundred twenty-six healthy men and women, aged 21-35 yr ("young" adults) or 50-80 yr ("older" adults) were studied: 25 young (13 men, 12 women) and 43 older (20 men, 23 women) sedentary individuals and 25 young (12 men, 13 women) and 33 older (20 men, 13 women) endurance-trained runners. The young and older endurance-trained subjects were matched for age-adjusted running performance as described previously by our laboratory (13), ran 52.2 ± 8.3 and 48.5 ± 5.6 km/wk, and had been training for 8 ± 1 and 18 ± 1 yr, respectively. The sedentary subjects had not participated in a regular aerobic exercise program for at least 1 yr before the start of the study. All of the older women were at least 2 yr postmenopausal (range = 2-23 yr), and 20 women were taking estrogen-based hormone supplements (12 sedentary individuals and 8 distance runners). The majority (18 of 20) of the users of hormone supplementation were on a oral regimen of conjugated estrogen (Premarin, 0.625-1.0 mg/day) in combination with medroxyprogesterone acetate (Provera, 2.5 mg/day); the remaining women were taking either Premarin or Provera only. We observed no influence of hormone replacement use. Therefore, the data were pooled and presented together. All premenopausal women were eumenorrheic as assessed by self-report of menstrual cycles, not taking oral contraceptives, and studied during the follicular phase of their menstrual cycle.
All subjects were normotensive (blood pressure
140/90), were free of
overt disease as assessed by medical history questionnaire, and had
plasma lipid and lipoprotein concentrations all within the normal range
(32). The older subjects were further evaluated for
clinical evidence of cardiovascular disease with a physical examination
and with resting and maximal exercise electrocardiograms. No subjects
were on medication other than hormone replacement, and all subjects
were nonsmokers. Before participation, all of the subjects had the
research study and its potential risks and benefits explained fully
before providing written, informed consent according to the guidelines
of the University of Colorado at Boulder and the University of Colorado
Health Sciences Center in Denver.
Body composition. Body mass was measured to the nearest 0.1 kg by using a medical beam balance (Detecto, Webb City, MO). Percent body fat was determined by dual-energy X-ray absorptiometry (model DPX-IQ, Lunar Radiation, Madison, WI) (28). Body mass index (BMI) was calculated as weight (in kg) divided by height (in m) squared. Minimal waist circumference was measured according to previously published guidelines (30).
Aerobic fitness.
Maximal oxygen consumption (
O2 max) was
used as a measure of aerobic fitness and was determined by using an
on-line computer-assisted open-circuit spirometry during incremental
exercise on a motorized treadmill as previously described
(13). A valid
O2 max was
accepted when at least three of the following criteria were met:
1) a plateau in oxygen consumption with increasing work rate
(<1
ml · kg
1 · min
1
or <100 ml/min), 2) a respiratory exchange ratio at maximal
exercise >1.10, 3) achievement of age-predicted maximal
heart rate (220
age), and 4) a rating of perceived
exertion >18 (Borg scale) (7).
Frequently sampled intravenous glucose tolerance test. All studies were performed ~24 h after the last bout of exercise in the endurance-trained subjects. To assess whole body insulin action, all subjects underwent an insulin-modified frequently sampled intravenous glucose tolerance test (FSIVGTT) after a 12-h overnight fast as previously described (1, 38). Briefly, intravenous cannulas were placed in both antecubital veins; one was for the administration of glucose and insulin, and the other was for venous sampling. Both catheters were kept patent throughout with a slow infusion of saline. After two baseline blood samples (3 ml), a bolus of glucose (300 mg/kg) was injected intravenously over 1 min at time 0 and regular insulin (0.03 U/kg; Humulin-Regular, Eli Lilly, Indianapolis IN) was injected 20 min later. Blood samples were collected at standard time points after glucose infusion for determination of plasma glucose and insulin concentrations. Plasma glucose was determined in duplicate by using a glucose hexokinase method (Gillford 203-S, Oberlin, OH), and insulin was determined by radioimmunoassay (45).
Glucose and insulin data from the FSIVGTT were subsequently analyzed using the minimal model method of Bergman to determine the insulin sensitivity index (ISI) (1), a measure of whole body insulin action. Calculation of ISI was made from a least squares fitting of the temporal pattern of glucose and insulin throughout the FSIVGTT (1). The acute insulin response to glucose (AIRG) was calculated as the mean increment in plasma insulin above baseline from 2 to 10 min after the intravenous administration of glucose (21). The disposition index (DI), an estimate of
-cell response to the prevailing degree of
insulin action, was determined as the product of ISI and
AIRG (4, 23).
Statistical analysis. The influence of age, gender, and training status on all variables were determined by a multifactor analysis of variance (age × gender × training status). When indicated by a significant F-value, specific mean comparisons were performed to identify significant group differences. Linear and stepwise regression analyses were performed to determine relations between the ISI and variables of interest. All data are expressed as means ± SE. Statistical significance was set at P < 0.05.
| |
RESULTS |
|---|
|
|
|---|
Age-related differences in the sedentary and endurance-trained
subjects.
Table 1 presents selected physical and
metabolic characteristics of the subjects. There were no age-related
differences in body mass in either the men or women. Percent body fat,
BMI, and waist circumference were higher (P < 0.05)
and
O2 max and fat-free mass were lower
in the older subjects compared with their respective young controls.
Fasting plasma glucose concentrations were higher (P < 0.05) with age, although within the normal range, in both the sedentary
and endurance-trained groups. There was no effect of age on fasting
plasma insulin concentrations in either the sedentary or
endurance-trained subjects. However, the endurance-trained subjects
demonstrated lower (P < 0.01) plasma insulin
concentrations than their sedentary peers.
|
Age-related differences in ISI in the sedentary and
endurance-trained subjects.
There was no main effect of gender on ISI, AIRG, or DI
(Table 2); therefore, the data were
pooled and presented together. ISI values were 44 and 36% lower in the
older vs. young sedentary (3.9 ± 0.3 vs. 7.0 ± 0.7 ×10
5 · min
1 · pmol
1 · l
1;
P < 0.01) and endurance-trained (7.9 ± 0.6 vs.
12.4 ± 1.0 ×10
5 · min
1 · pmol
1 · l
1;
P < 0.01) subjects, respectively (Fig.
1). However, the endurance-trained subjects demonstrated markedly higher (72-102%) ISI
values than their sedentary age-matched peers (P < 0.01). Moreover, ISI of the older endurance-trained group was similar
to that of the sedentary young group. There were no significant
age-related differences in AIRG in either the sedentary
(278.6 ± 32.9 vs. 255.4 ± 34.6 pmol/l) or endurance-trained
(131.5 ± 17.5 vs. 113.3 ± 14.5 pmol/l) subjects.
AIRG, however, was lower (P < 0.01) in the
endurance-trained subjects compared with their age-matched sedentary
counterparts. DI values were lower (P < 0.05) in the
older sedentary (862.5 ± 67.9 vs. 1,437.0 ± 133.4 10
5 · min
1) and
endurance-trained (872.6 ± 84.4 vs. 1,291.0 ± 161.6 10
5 · min
1) subjects
compared with their young counterparts. There was no main effect of
training status on DI.
|
|
Age-related differences in ISI in sedentary and endurance-trained
subjects with similar whole body adiposity.
Because body composition, particularly adiposity, is one of the
strongest predictors of insulin sensitivity in both men and women, we
sought to determine the influence of adiposity on ISI. First,
univariate correlations performed on the pooled population revealed
that ISI was inversely related (all P < 0.01) to body mass (r =
0.32), percent body fat (r =
0.60), BMI (r =
0.49), and waist circumference
(r =
0.48). In light of these relations, subgroups
(n = 62) of young and older sedentary and
endurance-trained subjects with similar levels of body fatness were
then compared. There was no main effect of gender in the subgroup
analysis, so the data were pooled and presented together (Table
3). In the subgroup of sedentary subjects
with similar percent body fat, there was no significant difference in
ISI in the older compared with the young subjects (4.4 ± 0.7 vs.
5.7 ± 1.0 ×10
4 · min
1 · pmol
1 · ml
1;
P = 0.13). However, in the endurance-trained
subgroup, ISI remained 33% lower (P < 0.01) in
the older vs. young subjects (8.7 ± 1.2 vs. 12.9 ± 1.9 × 10
4 · min
1 · pmol
1 · ml
1;
P < 0.01) (Fig. 2).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The primary new finding of the present study is that the age-related decline in insulin action typically observed in healthy, sedentary adults also is evident in adults who perform regular endurance exercise. In addition, whereas the age-associated decline in ISI was abolished in the sedentary adults after accounting for adiposity, the diminution in ISI with age in the endurance-trained adults was independent of this factor. To the best of our knowledge, this is the first study to demonstrate lower insulin action with age in endurance-trained adults. However, it is noteworthy that, despite this decline, ISI was higher at any age in endurance-trained compared with sedentary adults.
Deterioration of insulin action is considered to be a common characteristic of sedentary aging. In fact, our finding of a 53% reduction in insulin action in healthy older compared with young adults is consistent with previous observations (15, 27, 33, 37, 41). Importantly, the results of the present study extend these data by showing that insulin action declines with age in regularly exercising humans. Specifically, we observed a significant main effect of age on ISI in the endurance-trained groups. Indeed, ISI was 36% lower in the older compared with young endurance-trained adults.
There are two important limitations of our study that should be emphasized. First and foremost, because of the cross-sectional design of our study we cannot rule out the inherent possibility that genetic or constitutional factors may have influenced our findings. Although the levels of insulin sensitivity reported herein are consistent with previous studies involving both sedentary (1, 9) and physically active (22) populations, and the higher ISI values associated with regular physical activity in the present study are similar to those reported in response to endurance exercise training in older men (21, 22), our results should be viewed within the context and constraints of the study design. Second, the residual effects of the last bout of exercise on insulin sensitivity has been reported to persist for 40-72 h (25, 44). In the present study, ISI was determined ~20 h after the last bout of exercise in the endurance-trained groups. Because these adults exercise most days of the week, we reasoned that the 20-h postexercise condition used in the present study represents their normal biological state (habitually endurance trained). However, the influence of the last bout of exercise on ISI cannot be discounted and the reader should interpret the data presented accordingly.
Our results contradict the results of an earlier cross-sectional study
on the same topic (39). Seals et al. (39)
reported no age-associated increase in the plasma insulin responses to an oral glucose challenge in middle-aged and older endurance-trained athletes compared with young athletes. On the basis of these findings, the authors suggested that the decline in insulin sensitivity with age
may be prevented in adults who perform regular vigorous exercise.
Plasma insulin response to an oral glucose challenge, however, is at
best a crude marker of insulin action (1, 2). Although the
oral glucose tolerance test (OGTT) is clinically important for the
diagnosis of impaired glucose tolerance and diabetes, it is difficult
to tease out the contribution of insulin sensitivity, glucose
effectiveness, and
-cell responsiveness to the obeserved response
(3). Indeed, it has been suggested that only 37% of the
variance in plasma insulin responses to an OGTT can be attributed to
differences in insulin action (29). On the basis of the
use of a more sensitive assessment of whole body insulin action
(3), the results of the present study provide new insight
on the influence of regular aerobic exercise on the age-associated
decline in insulin sensitivity in adult humans. We are aware of no
other studies examining the influence of age and habitual
aerobic-endurance exercise on insulin action in adult male and female humans.
The mechanisms underlying the age-associated decline in insulin sensitivity are not completely understood. Because a number of factors can influence the metabolic actions of insulin, it has been suggested that the age-associated decline in insulin sensitivity is not solely due to aging per se but rather to other concomitants of aging, particularly increasing whole body adiposity (6, 14), body fat distribution (16, 27), and physical inactivity (18, 42). Kohrt et al. (27) have reported that age-related insulin resistance is more closely associated with abdominal adiposity than with age. Using the hyperinsulinemic euglycemic clamp procedure to quantify insulin action in groups of young and older adults, the authors noted that waist circumference accounted for >40% of the variance in insulin action, whereas age accounted for <20% of the total variance and, importantly, <2% of the variance when adjusted for waist circumference. Similar findings involving relations between age, BMI, and insulin sensitivity have been reported by the European Group for the Study of Insulin Resistance in 1,146 healthy Caucasian men and women (14).
In the present study, we observed no age-related decline in insulin action in our subgroup of sedentary subjects with similar levels of body fatness. These findings support the postulate that reductions in insulin sensitivity with age in sedentary humans are dependent on age-associated increases in adiposity (14, 27). However, this does not appear to be the case in endurance-trained adults. A novel finding of the present study is that, in contrast to sedentary aging, the decline in insulin action with age in endurance-trained adults appears to be independent of adiposity. When we compared subgroups of young and older runners with similar body fat levels the magnitude of the age-related difference in ISI was similar to that observed in the whole groups (33 vs. 36%). These findings suggest that the age-associated decline in ISI in sedentary and endurance-trained subjects does not share a common etiology.
Given the present study design, we can only speculate on potential mechanisms responsible for the age-related decline in ISI in the endurance-trained adults. One possibility is a reduction in exercise training intensity with age. For example, our laboratory (13) and others (34) have shown that in habitually endurance-trained adults absolute training intensity (running velocity) decreases with advancing age as a consequence of reduced exercise capacity. Thus age-associated reductions in exercise training intensity may result in a training stimulus insufficient to maintain the high levels of muscle insulin sensitivity (the main determinant of whole body insulin action) established at a young age. It is also possible that regular aerobic exercise does not affect the age-related decline in GLUT-4 protein concentration observed in sedentary adults (19). Future studies are needed to determine the mechanisms responsible for the decline in insulin sensitivity with age in endurance-trained adults.
To our knowledge, this is the first study to demonstrate an age-related
decline in DI in both sedentary and endurance-trained adults. DI was
~35% lower in the older compared with young adults regardless of
training status. In accordance with the hyperbolic relationship
between insulin secretion and insulin sensitivty advocated by Elbein et
al. (12) and Kahn et al. (23), this finding
suggests that the ability of the
-cell to compensate for the degree
of insulin sensitivity declines with age and is unaffected by habitual
physical activity. Indeed, we observed no age-related increase in
AIRG values in either the sedentary or endurance-trained
subjects, indicating that
-cell insulin secretion was not modified
in response to reduced insulin action in either group. DI has been
shown to be lower in other populations with reduced insulin sensitivity
(12).
In light of the present findings that ISI declines with age even in adult humans who exercise vigorously, it is clinically important to emphasize the following. First, ISI was much greater at any age in regularly exercising adults. Second, the main effect of exercise status on ISI was twice as strong as age. Thus, although habitual endurance exercise does not appear to prevent the age-related decline in ISI in adult humans, the endurance-trained adults demonstrated greater insulin at any age compared with their sedentary peers. This likely contributes to the lower incidence of metabolic and cardiovascular diseases observed in adults who exercise regularly (35).
In conclusion, the results of the present study suggest that habitual endurance exercise does not prevent the age-associated decline insulin action. As in sedentary adults, we observed a significant reduction in ISI in the young vs. older endurance-trained adults. However, in contrast to sedentary adults, the reduction in insulin sensitivity with age in endurance-trained adults appears to be independent of whole body adiposity.
| |
ACKNOWLEDGEMENTS |
|---|
We thank all of the subjects who participated in the study, Mary Jo Reiling for technical assistance, and Cyndi Long and Yoli Casas for administrative assistance.
| |
FOOTNOTES |
|---|
This research was supported by National Institutes of Health (NIH) RO1 Awards HL-39966, AG-06537, and AG-13038 (to D. R. Seals) and Division of Research Resources Research Grant 5 01 RR-00051. C. A. DeSouza was supported initially by a Research Supplement to Minority Individuals in Postdoctoral Training RO1 Award HL-39966 and Award AG-13038 and later by a NIH KO1 Award HL-03840 and a Clinical Research Award from the American Diabetes Association. P. P. Jones was initially supported by NIH F32 Award AG-05705 and later by NIH KO1 Award AG-00828. H. Tanaka was supported by NIH KO1 Award AG-00847.
Address for reprint requests and other correspondence: C. DeSouza, Univ. of Colorado, Dept. of Kinesiology and Applied Physiology, 354 UCB, Boulder, CO 80309 (E-mail: desouzac{at}colorado.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
August 30, 2002;10.1152/japplphysiol.00315.2002
Received 10 April 2002; accepted in final form 23 August 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Bergman, R.
Toward physiological understanding of glucose tolerance.
Diabetes
38:
1512-1527,
1989.
2.
Bergman, R,
Beard J,
and
Chen M.
The minimal modeling method. Assesment of insulin sensitivity and
-cell function in vivo.
In: Methods in Diabetes Research. Volume II: Clinical Methods, edited by Clarke W,
Larner J,
and Pohl S.. New York: Wiley, 1986, p. 15-34.
3.
Bergman, R,
Finegood D,
and
Ader M.
Assessment of insulin sensitivity in vivo.
Endocr Rev
6:
45-86,
1985.
4.
Bergman, R,
Phillips L,
and
Cobelli C.
Physiologic evaluation of factors controlling glucose tolerance in man.
J Clin Invest
68:
1456-1467,
1981.
5.
Blair, S,
Kohl H,
Paffenbarger R,
Clark D,
and
Cooper K.
Physical fitness and all-cause mortality. A perspective study of healthy men and women.
JAMA
262:
2395-2401,
1989.
6.
Boden, G,
Chen X,
DeSantis R,
and
Kendrick Z.
Effects of age and body fat on insulin resistance in healthy men.
Diabetes Care
16:
728-733,
1993.
7.
Borg, G.
Perceived exertion as an indicator of somatic stress.
Scand J Rehabil Med
2:
92-98,
1970.
8.
Bressler, P,
Bailey S,
Matsuda M,
and
DeFronzo R.
Insulin resistance and coronary artery disease.
Diabetologia
39:
1345-1350,
1996.
9.
Chen, M,
Bergman R,
Pacini G,
and
Porte D.
Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased
-cell function.
J Clin Endocrinol Metab
60:
13-20,
1985.
10.
Chen, M,
Bergman R,
and
Porte D, Jr.
Insulin resistance and
-cell dysfunction in aging: the importance of dietary carbohydrate.
J Clin Endocrinol Metab
75:
249-253,
1988.
11.
DeFronzo, R.
Glucose intolerance with aging.
Diabetes Care
4:
493-501,
1981.
12.
Elbein, S,
Wegner K,
and
Kahn S.
Reduced beta-cell compensation to insulin resistance associated with obesity in memebers of caucasian familial type 2 diabetic kindreds.
Diabetes Care
23:
221-227,
2000.
13.
Evans, S,
Davy K,
Stevenson E,
and
Seals D.
Physiological determinants of 10-km performance in highly trained female runners of different ages.
J Appl Physiol
78:
1931-1941,
1995.
14.
Ferrannini, E,
Vichi S,
Beck-Nielsen H,
Laakso M,
Paolisso G,
and
Smith U.
Insulin action and age.
Diabetes
45:
947-953,
1996.
15.
Fink, R,
Kolterman O,
Griffin J,
and
Olefsky J.
Mechanisms of insulin resistance and aging.
J Clin Invest
71:
1523-1535,
1983.
16.
Halter, J.
Carbohydrate metabolism.
In: Handbook of Physiology. Aging. Bethesda, MD: Am. Physiol. Soc, 1995, p. 119-146, sect. 11, chapt. 7.
17.
Harris, M,
Hadden W,
Knowler W,
and
Bennett P.
Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20-74 yr.
Diabetes
36:
523-534,
1987.
18.
Hollenbeck, C,
Haskell W,
Rosenthal M,
and
Reaven G.
Effect of habitual physical activity on regulation of insulin-stimulated glucose disposal in older males.
J Am Geriatr Soc
33:
273-277,
1984.
19.
Houmard, JA,
Weidner MD,
Dolan PL,
Leggett-Frazier N,
Gavigan KE,
Hickey MS,
Tyndall GL,
Zheng D,
Alshami A,
and
Dohm GL.
Skeletal muscle GLUT4 protein concentration and aging in humans.
Diabetes
44:
555-560,
1995.
20.
Howard, G,
O'Leary D,
Zaccaro D,
Haffner S,
Rewers M,
Hamman R,
Selby J,
Saad M,
Savage P,
and
Bergman R.
Insulin sensitivity and atherosclerosis.
Circulation
93:
1809-1817,
1996.
21.
Kahn, S,
Larson V,
Beard J,
Cain K,
Fellingham G,
Schwartz R,
Veith R,
Stratton J,
Cerqueira M,
and
Abrass I.
Effect of exercise on insulin action, glucose tolerance, and insulin secretion in aging.
Am J Physiol Endocrinol Metab
258:
E937-E943,
1990.
22.
Kahn, S,
Larson V,
Schwartz R,
Beard J,
Cain K,
Fellingham G,
Stratton J,
Cerqueira M,
and
Abrass I.
Exercise training delineates the importance of
-cell dysfunction to glucose intolerance of human aging.
J Clin Endocrinol Metab
74:
1336-1342,
1992.
23.
Kahn, S,
Prigeon R,
McCulloch D,
Boyko E,
Bergman R,
Schwartz M,
Neifing J,
Ward W,
Beard J,
Palmer J,
and
Porte D, Jr.
Quantification of the relationship between insulin sensitivity and beta cell function in human subjects: evidence for a hyperbolic function.
Diabetes
42:
1663-1672,
1993.
24.
Kamide, K,
Rakugi H,
Nakano N,
Ohishi M,
Nakata Y,
Takami S,
Katsuya T,
Higaki J,
and
Ogihara T.
Insulin resistance is related to silent cerebral infarction in patients with essential hypertension.
Am J Hypertens
10:
1245-1249,
1997.
25.
King, D,
Baldus P,
Sharp R,
Kesl L,
Feltmeyer T,
and
Riddle M.
Time course for exercise-induced alterations in insulin action and glucose tolerance in middle-aged people.
J Appl Physiol
78:
17-22,
1995.
26.
King, D,
Dalsky G,
Staten M,
Clutter W,
Houten DV,
and
Holloszy J.
Insulin action and secretion in endurance-trained and untrained humans.
J Appl Physiol
63:
2247-2252,
1987.
27.
Kohrt, W,
Kirwin J,
Staten M,
Bourey R,
King D,
and
Holloszy J.
Insulin resistance in aging is related to abdominal obesity.
Diabetes
42:
273-281,
1993.
28.
Kohrt, W,
Malley M,
Dalsky G,
and
Holloszy J.
Body composition of healthy sedentary and trained, young and older men and women.
Med Sci Sports Exerc
24:
832-837,
1992.
29.
Laakso, M.
How good a marker is insulin level for insulin resistance?
Am J Epidemiol
137:
959-965,
1993.
30.
Lohman, T,
Roche A,
and
Mortorell R.
Athropometric Standardization Reference Manual. Champaign, IL: Human Kinetics, 1988.
31.
Mykkanen, L,
Haffner S,
Ronnemaa T,
Bergman R,
and
Laakso M.
Low insulin sensitivity is associated with clustering of cardiovascular disease risk factors.
Am J Epidemiol
146:
315-321,
1997.
32.
National Cholesterol Education Program.
Detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II).
Circulation
89:
1329-1445,
1994.
33.
O'Shaughnessy, I,
Kasdorf G,
Hoffmann R,
and
Kalhoff R.
Does aging intensify the insulin resistance of human obesity.
J Clin Endocrinol Metab
74:
1075-1081,
1992.
34.
Pollock, M,
Foster C,
Knapp D,
Rod J,
and
Schmidt D.
Effect of age and training on aerobic capacity and body composition of master athletes.
J Appl Physiol
62:
725-731,
1987.
35.
Powell, K,
Thompson P,
Caspersen C,
and
Kendrick J.
Physical activity and the incidence of coronary heart disease.
Annu Rev Public Health
8:
253-287,
1987.
36.
Pratley, R,
Hagberg J,
Rogus E,
and
Goldberg A.
Enhanced insulin sensitivity and lower waist-to-hip ratio in master athletes.
Am J Physiol Heart Circ Physiol
268:
H484-H490,
1995.
37.
Rowe, J,
Minaker K,
Pallotta J,
and
Flier J.
Characterization of the insulin resistance of aging.
J Clin Invest
71:
1581-1587,
1983.
38.
Saad, M,
Anderson R,
Laws A,
Watanbe R,
Kades W,
Chen Y-DI,
Sands R,
Peter D,
Savage P,
and
Bergman R.
A comparison between the minimal model and glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance.
Diabetes
43:
1114-1121,
1994.
39.
Seals, D,
Hagberg J,
Hurley B,
Dalsky A,
Ehsani A,
and
Holloszy J.
Glucose tolerance in young and older athletes and sedentary men.
J Appl Physiol
56:
1521-1525,
1984.
40.
Seals, D,
Hagberg J,
Hurley B,
Ehsani A,
and
Holloszy J.
Effects of endurance training on glucose tolerance and plasma lipid levels in older men and women.
JAMA
252:
645-649,
1984.
41.
Supiano, M,
Hogikyan R,
Morrow L,
Ortiz-Alonso F,
Herman W,
Galechi A,
and
Halter J.
Aging and insulin sensitivity: role of blood pressure and sympathetic nervous system activity.
J Gerontol
48:
M237-M243,
1993.
42.
Tonino, R.
Effect of physical training on the insulin resistance of aging.
Am J Physiol Endocrinol Metab
256:
E352-E356,
1989.
43.
Yki-Jarvinen, H.
Role of insulin resistance in the pathogenesis of NIDDM.
Diabetologia
38:
1378-1388,
1995.
44.
Young, J,
Enslin J,
and
Kuca B.
Exercise intensity and glucose tolerance in trained and nontrained subjects.
J Appl Physiol
67:
39-43,
1989.
45.
Zaharko, D,
and
Beck L.
Studies of a simplified plasma insulin immunoassay using cellulose powder.
Diabetes
17:
444-447,
1968.
This article has been cited by other articles:
![]() |
S. B. Racette, E. M. Evans, E. P. Weiss, J. M. Hagberg, and J. O. Holloszy Abdominal adiposity is a stronger predictor of insulin resistance than fitness among 50-95 year olds. Diabetes Care, March 1, 2006; 29(3): 673 - 678. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. DiPietro, J. Dziura, C. W. Yeckel, and P. D. Neufer Exercise and improved insulin sensitivity in older women: evidence of the enduring benefits of higher intensity training J Appl Physiol, January 1, 2006; 100(1): 142 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Short, J. L. Vittone, M. L. Bigelow, D. N. Proctor, R. A. Rizza, J. M. Coenen-Schimke, and K. S. Nair Impact of Aerobic Exercise Training on Age-Related Changes in Insulin Sensitivity and Muscle Oxidative Capacity Diabetes, August 1, 2003; 52(8): 1888 - 1896. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |